BAY1237592

Phase 1Small molecule

BAY1237592 is one of 9 small molecule programs targeting Chronic Thromboembolic Pulmonary Hypertension. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Chronic Thromboembolic Pulmonary HypertensionActive, not recruiting

Chronic Thromboembolic Pulmonary HypertensionPhase 1

Active, not recruiting

Competition

Competitive Landscape

10 competitors in Chronic Thromboembolic Pulmonary Hypertension

#DrugCompanyPhaseTrials

Adempas

Bayer

Phase 3

5 2

Opsumit

Johnson & Johnson

Phase 3

5 3

Letairis

Gilead

Phase 3

2 4

Tracleer

Johnson & Johnson

Phase 3

2 5

Uptravi

Johnson & Johnson

Phase 3

1 6

Treprostinil Sodium

United Therapeutics

Phase 3

1 7

N-Acetyl Cyteien

SStanford University

Preclinical

1 8

BAY1237592

Bayer

Phase 1

1 9

Adempas

Bayer

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Chronic Thromboembolic Pulmonary Hypertension1 trial

This Study Tests the Safety of Inhaled BAY1237592, How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Completed· Bayer logo

Bayer·Phase 1·NCT03754660·38 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for BAY1237592. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — BAY1237592 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for BAY1237592. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Bayer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: Bayer

BAY1237592

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Chronic Thromboembolic Pulmonary Hypertension1 trial

References

Drug Info

Quick Facts

Related News